VeraDermics Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Public

  • Employees
  • 21

Employees

  • Stock Symbol
  • MANE

Stock Symbol

  • Share Price
  • $129.66
  • (As of Friday Closing)

VeraDermics General Information

Description

Veradermics Inc clinical-stage biopharmaceutical company focused on developing therapeutics to address pervasive treatment challenges in prevalent aesthetic and dermatological conditions. The company operates in a single segment of allocating resources, assessing performance, and making operating decisions.

Contact Information

Website
www.veradermics.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 470 James Street
  • Suite 14
  • New Haven, CT 06513
  • United States
+1 (228)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
NYS
Vertical(s)
Life Sciences
Corporate Office
  • 470 James Street
  • Suite 14
  • New Haven, CT 06513
  • United States
+1 (228)

VeraDermics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

VeraDermics Stock Performance

As of 13-Nov-2026, VeraDermics’s stock price is $129.66. Its current market cap is $5.47B with 42.2M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$129.66 $135.29 $32.00 - $156.63 $5.47B 42.2M 753K -$3.89

VeraDermics Financials Summary

As of 30-Sep-2026, VeraDermics has a trailing 12-month revenue of null.

In Thousands,
USD 		TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 4,245,540
Revenue 0 0 0 0
EBITDA (106,901) (71,557) (26,384) (17,324)
Net Income (93,580) (69,995) (26,488) (16,490)
Total Assets 807,215 152,619 55,535 17,562
Total Debt 371 4 0 786
Public Fundamental Data provided by Morningstar, Inc. disclaimer

VeraDermics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore VeraDermics‘s full profile, request access.

Request a free trial

VeraDermics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion
Price		 % Owned

This information is available in the PitchBook Platform. To explore VeraDermics‘s full profile, request access.

Request a free trial

VeraDermics Patents

  • 136

    Total Documents Applications and Grants

  • Total Patents Families

  • 9

    Granted

  • 119

    Pending

  • Expiring in next 12 mo

VeraDermics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026232168-A1 Method of treating hair loss Pending 02-May-2025
US-20250332108-A1 Compositions and methods of use for modified release minoxidil Inactive 24-Apr-2024
US-20250332109-A1 Compositions and methods of use for modified release minoxidil Inactive 24-Apr-2024
US-20250345330-A1 Compositions and methods of use for modified release minoxidil Inactive 24-Apr-2024
US-20260053800-A1 Compositions and methods of use for modified release minoxidil Pending 24-Apr-2024 A61K9/2054
To view VeraDermics’s complete patent history, request access »

VeraDermics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

VeraDermics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore VeraDermics‘s full profile, request access.

Request a free trial

VeraDermics ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view VeraDermics’s complete esg history, request access »

VeraDermics FAQs

  • When was VeraDermics founded?

    VeraDermics was founded in 2019.

  • Where is VeraDermics headquartered?

    VeraDermics is headquartered in New Haven, CT.

  • What is the size of VeraDermics?

    VeraDermics has 21 total employees.

  • What industry is VeraDermics in?

    VeraDermics’s primary industry is Drug Discovery.

  • Is VeraDermics a private or public company?

    VeraDermics is a Public company.

  • What is VeraDermics’s stock symbol?

    The ticker symbol for VeraDermics is MANE.

  • What is the current stock price of VeraDermics?

    As of 13-Nov-2026 the stock price of VeraDermics is $129.66.

  • What is the current market cap of VeraDermics?

    The current market capitalization of VeraDermics is $5.47B.

  • What is VeraDermics’s annual earnings per share (EPS)?

    VeraDermics’s EPS for 12 months was -$3.89.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process